Company
Tectonic Therapeutic, Inc. (TECX)
Standardized SEC financial data for Tectonic Therapeutic, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001681087 · NASDAQ · Biological Products, (No Diagnostic Substances).
Return on equity
-29.5%
ROIC
-579.4%
Free cash flow
-$60.3M
Debt / equity
0.06×
Current ratio
26.63×
EPS (diluted)
$-4.05
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $87.2M | $83.1M | $72.2M | $37.0M | $41.4M | $63.5M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $260.2M | $190.1M | $92.6M | $29.4M | $141.8M | $254.9M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$98.8M | -$98.0M | -$97.2M | -$40.7M | -$59.1M | -$60.1M |
| Capital expenditures |
Get TECX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/TECX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/TECX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"